Flax "milk" for Cardiotoxicity

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cardiotoxicity
Flax "milk" - DietarySupplement
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial is examining the use of flaxseed to prevent heart failure in women with breast cancer who are also receiving treatment with doxorubicin and trastuzumab.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 1 year

1 year
Left ventricular ejection fraction (LVEF) change

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Flax "milk"
1 of 2
Oat fibre "milk"
1 of 2
Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: Flax "milk" · No Placebo Group · N/A

Flax "milk"
DietarySupplement
Experimental Group · 1 Intervention: Flax "milk" · Intervention Types: DietarySupplement
Oat fibre "milk"
DietarySupplement
Experimental Group · 1 Intervention: Oat fibre "milk" · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

St. Boniface HospitalLead Sponsor
48 Previous Clinical Trials
11,030 Total Patients Enrolled
1 Trials studying Cardiotoxicity
43 Patients Enrolled for Cardiotoxicity
Davinder S Jassal, MDPrincipal InvestigatorUniversity of Manitoba

Eligibility Criteria

Age 18+ · Female Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are at least 18 years old.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 23rd, 2021

Last Reviewed: October 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.